| Date Filed | Type | Description |
| 07/21/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/17/2023 |
4
| Henderson Molly (CFO and CBO) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 25,000 shares
@ $1, valued at
$25k
|
|
| 07/17/2023 |
4
| Curran Terrie (President and Chief Executive) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 200,000 shares
@ $0
Disposed/sold 175,000 options
@ $32.2, valued at
$5.6M
Disposed/sold 225,000 options
@ $39.11, valued at
$8.8M
|
|
| 07/17/2023 |
4
| Nabulsi Azmi (COO) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 110,000 shares
@ $0
Disposed/sold 70,000 options
@ $32.2, valued at
$2.3M
Disposed/sold 150,000 options
@ $39.11, valued at
$5.9M
|
|
| 06/05/2023 |
4
| Parikh Asit (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 shares
@ $7.4, valued at
$111k
Disposed/sold 15,000 options to buy
@ $7.4, valued at
$111k
|
|
| 06/05/2023 |
4
| Henderson Molly (CFO and CBO) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Sold 1,960 shares
@ $11.4121, valued at
$22.4k
|
|
| 05/30/2023 |
4
| Topper James N (10% Owner) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 9,000 shares
@ $0
Granted 15,000 options to buy
@ $11.72, valued at
$175.8k
|
|
| 05/30/2023 |
4
| Stenhouse Mark (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 9,000 shares
@ $0
Granted 15,000 options to buy
@ $11.72, valued at
$175.8k
|
|
| 05/30/2023 |
4
| Socks David A (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 9,000 shares
@ $0
Granted 15,000 options to buy
@ $11.72, valued at
$175.8k
|
|
| 05/30/2023 |
4
| Parikh Asit (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 9,000 shares
@ $0
Granted 15,000 options to buy
@ $11.72, valued at
$175.8k
|
|
| 05/30/2023 |
4
| FIELDS HEIDI (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 9,000 shares
@ $0
Granted 15,000 options to buy
@ $11.72, valued at
$175.8k
|
|
| 05/30/2023 |
4
| KARBE FRANK (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 9,000 shares
@ $0
Granted 15,000 options to buy
@ $11.72, valued at
$175.8k
|
|
| 05/30/2023 |
4
| COLA MICHAEL F (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 9,000 shares
@ $0
Granted 15,000 options to buy
@ $11.72, valued at
$175.8k
|
|
| 05/23/2023 |
4
| Henderson Molly (CFO and CBO) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Sold 2,110 shares
@ $12.8744, valued at
$27.2k
|
|
| 03/03/2023 |
4
| Henderson Molly (CFO and CBO) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Sold 2,032 shares
@ $8.5309, valued at
$17.3k
|
|
| 02/14/2023 |
4
| Parikh Asit (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Bought 5,000 shares
@ $7.732, valued at
$38.7k
|
|
| 01/20/2023 |
4
| Curran Terrie (President and Chief Executive) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 97,500 shares
@ $0
Sold 5,821 shares
@ $8.1995, valued at
$47.7k
Granted 162,500 options to buy
@ $8.35, valued at
$1.4M
|
|
| 01/20/2023 |
4
| Nabulsi Azmi (COO) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 45,000 shares
@ $0
Granted 75,000 options to buy
@ $8.35, valued at
$626.3k
|
|
| 01/20/2023 |
4
| Henderson Molly (CFO and CBO) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 33,000 shares
@ $0
Granted 55,000 options to buy
@ $8.35, valued at
$459.3k
|
|
| 01/12/2023 |
4
| Parikh Asit (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Bought 5,000 shares
@ $7, valued at
$35k
|
|
| 11/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/26/2022 |
4
| Topper James N (10% Owner) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $10.02, valued at
$200.4k
|
|
| 09/02/2022 |
4
| Curran Terrie (President and Chief Executive) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 7,500 shares
@ $0 |
|
| 09/02/2022 |
4
| Nabulsi Azmi (COO) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 7,500 shares
@ $0 |
|
| 09/02/2022 |
4
| Henderson Molly (CFO and CBO) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 7,500 shares
@ $0 |
|
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|